SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
SUDOSCAN has demonstrated its clinical utility in Nephrology.
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
Objective screening of diabetes risk through non invasive assessment of Sudomotor function using Ezscan score
SUDOSCAN is a medical device that offers a stimulation of the sweat glands that assess small nerve fibers.
Explore how SUDOSCAN supports early diabetic neuropathy detection and helps monitor diabetes-related complications over time.
Assess small fiber neuropathies across neurological and metabolic conditions, supporting earlier detection and better patient management.
Detect chemotherapy-induced peripheral neuropathy and support treatment decisions to help limit worsening symptoms in cancer patients.
Identify autonomic neuropathy risks in nephrology, including diabetic kidney disease and intradialytic hypotension in hemodialysis patients.
Monitor patient outcomes over time, tracking neuropathy progression and the impact of treatments or lifestyle changes.
An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy.
Simple results obtained in 3 minutes.